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Stem cells have important clinical and experimental potentials. Tro-
phoblast stem (TS) cells possess the ability to differentiate into tropho-
blast subtypes in vitro and contribute to the trophoblast lineage in vivo.
Suppressor of cytokine signaling 3 (SOCS3) is a negative regulator of cyto-
kine signaling. Targeted disruption of SOCS3 revealed embryonic lethal-
ity on E12.5; it was caused by placental defect with enhanced leukemia
inhibitory factor receptor signaling. A complementation of the wild-type
(WT) placenta by using tetraploid rescue technique showed that the
embryonic lethality in SOCS3-deficient embryo was due to the placental
defect. Here we demonstrate that TS cells supplementation rescues pla-
cental defect in SOCS3-deficient embryos. In the rescued placenta, TS
cells were integrated into the placental structure, and a substantial struc-
tural improvement was observed in the labyrinthine layer that was dis-
rupted in the SOCS3-deficient placenta. Importantly, by supplying TS
cells, living SOCS3-deficient embryoswere detected at term.These results
indicate a functional contribution of TS cells in the placenta and their
potential application.
In mammals, trophoblast cells in the placenta are essential for the growth
and survival of the embryo. Trophoblast stem (TS)3 cells have been established
from either blastocysts or early postimplantation trophoblasts in the presence
of fibroblast growth factor 4 (FGF4) (1). These cell lines differentiated into
trophoblast subtypes in vitro and have the potential to contribute to the pla-
centa in chimeras in vivo. However, it remains to be clarified whether the in
vivo differentiated trophoblasts from TS cells are functional.
SOCS3 is an essential negative regulator of leukemia inhibitory factor recep-
tor signaling in trophoblast differentiation (2). Targeted disruption of SOCS3
demonstrates embryonic lethality with placental defect (2, 3). In the SOCS3-
deficient placenta, an excess status of trophoblast giant cell differentiation is
observed. The embryonic lethality in SOCS3/ embryos is rescued by the
complementation of wild-type tetraploid embryos, thus demonstrating an
essential role of SOCS3 in placental development and a non-essential role in
embryo development (2). To explore the potential of TS cells in rescuing the
placental defect in SOCS3-deficient mice, we attempted to prepare a chimera
by using SOCS3/ embryo and WT TS cells.
MATERIALS ANDMETHODS
Mice—ThegenerationofSOCS3-disruptedmicewasasdescribed inaprevious
study (2). Using tail biopsies, genotyping was performed by PCR as described.
Mutant phenotypes were analyzed in a mixed 129/Sve, C57Bl/6 background.
TS Cell Injections—TS cell lines were derived from B5/enhanced green
florescent protein (EGFP) transgenic mice (4) (kindly supplied by Dr. J.
Rossant) that ubiquitously express EGFP. These cells had already been
cultured for more than 30 passages and showed a typical colony (Fig. 1, left).
TS cells were maintained in the presence of FGF4 and conditioned medium
from mouse embryonic fibroblast cells (1). On E2.5, morula stage embryos
were collected from SOCS3 heterozygous intercrosses, the zonae were
removed, and embryos were aggregated with 10–15 TS cells in drop cul-
ture. After overnight culture, the developed blastocysts were transferred to
the uteri of pseudopregnant females. In the injection method, 10–15 TS
cells were injected into the blastocysts from the SOCS3 heterozygous inter-
crosses. Blastocysts in which only the injection medium were used as the
control. After injection, 8–10 blastocysts per pseudopregnant female were
transferred into the uteri. Tetraploid rescue experiments were performed
as described previously (2).
Histological Analysis—Freshly isolated placenta were fixed in 4% paraform-
aldehyde, dehydrated, embedded in paraffin, and sectioned (4 m). Sections
were analyzed by hematoxylin/eosin staining.
Immunohistochemistry—Immunohistochemical staining of cells was per-
formed according to standard protocols as described previously (5). In brief,
GFP expression in sections of the placenta was identified by overnight incuba-
tion of formalin-fixed, decalcified, paraffin-embedded sections at 4 °C with a
rabbit anti-GFP antibody (1:300) (Molecular Probes, Eugene, OR). The pri-
mary antibody was visualized with a biotinylated goat anti-rabbit secondary
antibody (1-h incubation, room temperature, dilution of 1:200), and peroxi-
dase-conjugated avidin (ABC kit, Vector Laboratories) by using NovaRED
(Vector Laboratories) as the substrate; counterstaining was performed with
Harris hematoxylin (Surgipath Medical Industries, Richmond, IL).
RESULTS
To produce a chimera with SOCS3/ embryos and TS cells, we first
attempted an aggregation method (6). To visualize and monitor the TS
cells, we used GFP-positive TS cells. However, the ability of the TS cells to
integrate into the blastocysts was poor and the ratio of chimerism in the
placenta was low (less than 5%; data not shown). We were not able to detect
any SOCS3/ embryos at term among more than 100 embryos after
aggregation. Next, we attempted the injection method. Ten to fifteen TS
cells were injected into blastocysts from heterozygous intercrosses (Fig. 1,
right). Generally, SOCS3/ embryos die between E11.5–13.5 and after
E15.5; no SOCS3/ embryos survived (2). We then recovered embryos at
term (E18.5–19.5) and analyzed their genotypes. In the control, there were
no SOCS3/ embryos on E18.5. In contrast, 5 SOCS3/ embryos were
detected, among TS-cell injected embryos (p  0.001, compared with the
control), although, one embryo was dead at term (Table 1). The average
embryo weight of SOCS3/, SOCS3/, and SOCS3/ was 1.57 
0.22 g, 1.59  0.14 g, and 1.15  0.17 g (mean  S.D. of living pups),
respectively. Although, the intrauterine growth of the rescued SOCS3/
embryos was significantly impaired, four out of five pups were alive. In
contrast, in tetraploid rescue experiments, the sizes of the rescued
SOCS3/ embryo were comparable with that of/ and/ (data not
sown) (2). Next, histological analysis of the placentas was performed (Fig.
2). In the SOCS3 deficient placenta, trophoblast giant cells (TGCs) occu-
pied in the labyrinth, and there was no intact labyrinthine layer that is
essential for the exchange of oxygen and nutrition (Fig. 2, right). In con-
trast, in the rescued SOCS3/ placenta, intact labyrinthine layer was
detected (Fig. 2, middle, arrows) despite the presence of aberrant TGCs in
the labyrinth (Fig. 2, middle, asterisk). The degree of improvement in the
rescued placenta was correlated to the embryo weight (data not shown).
Immunohistochemistry using anti-GFP antibody demonstrated diffuse
contribution of GFP-positive trophoblasts (Fig. 3A). Particularly, many
GFP-positive cells were detected in the intact labyrinthine structure (Fig.
3A, panel a, arrow) and chorion (Fig. 3A, panel c, arrow) where the tropho-
blast stem cells reside (7). Interestingly, some eutopic TGCs were also
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GFP-positive (Fig. 3A, panel b, arrow), suggesting that TS cells could dif-
ferentiate into TGCs in intact localization. The ratio of the contribution of
GFP-positive trophoblasts to the placentas was significantly correlated to
the weight of SOCS3/ embryos (r 0.96, p 0.05, data not shown). No
GFP-positive cells were detected in the embryos (data not shown).
DISCUSSION
Our results provided compelling evidence that there was a functional con-
tribution of TS cells to the placenta in vivo. Although, the rescued SOCS3/
embryos demonstrated intrauterine growth retardation, indicating partial res-
cue of placental function comparing with tetraploid rescue experiments, the
presence of SOCS3/ embryos at termwithTS cell-injected placenta clearly
indicates that the TS cells support the placental function until term as well as
the histological improvement in the placental structure.
It is intriguing that the integrated TS cells differentiated properly even in
SOCS3/ placenta depending on the localization in the placenta. These results
imply that the aberrant differentiation in SOCS3/ trophoblasts was a cell-
autonomous effect, and its effect did not affect the programmed differentiation
property.
The embryonic lethality associated with many targeted mutations in mice has
been shown to involve placental defects (7). Importantly, the associated insuffi-
ciencies in nutrient, gas, and waste exchange cause a secondary embryonic phe-
notype. In this case, tetraploid complementation rescues placental trophoblast
defect andenables identificationof theembryonicphenotypes that arise secondary
to the defects in extraembryonic cells (8, 9). Although, the efficiency of TS cells
rescue is less than that in tetraploid rescue (5 versus 12%, Table 1), TS cells rescue
experiments involving simple techniques can be used for this purpose. Whether
this strategy couldbeused for rescuingothermutations impactingplacental devel-
opment is an important question and further study is required in this regard.
However, basedonour results, and theoretical knowledge, it is strongly speculated
that trophoblast stemcells could rescueothermutationswithplacentaldefect.The
potential of TS cells to rescue placental defect indicates a newpossible application
in the treatment of placental abnormality.
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FIGURE 1. Left, TS cell colony in FGF4 and conditioned medium. Right, 10–15 EGFP-TS
cells were injected into blastocysts, and GFP cells could be visualized under a fluores-
cent microscope before being transferred into the uteri of pseudopregnant females.
FIGURE 2. Placentas from wild-type (left, E18.5) and SOCS3-deficient (right, E12.5)
embryos. The placenta from rescued SOCS3-deficient (middle, E18.5) embryo demon-
strates partial intact labyrinthine structure (arrowhead) compared with SOCS3-deficient
placenta (right). An aberrant giant cell in the labyrinth has been indicated by an asterisk.
de, deciduas; gi, trophoblast giant cells; sp, spongiotrophoblast layer; la, labyrinthine
layer.
FIGURE 3. Immunohistochemistry for GFP in rescued placenta shows the integra-
tionofGFP trophoblast in theSOCS3-deficientplacenta.A, GFP immunostaining in
WT TS cell-injected SOCS3/ placenta (0X). B, GFP immunostaining in control pla-
centa (no TS cells injection) (40). Panels a–c, the highermagnification of the squares in
Fig. 3A. Panel a, intact labyrinthine structure. Panel b, GFP giant cells. Panel c, GFP
trophoblast cells in chorion (arrowhead indicates GFP cells). Note that GFP cells
reside particularly in the chorion and intact labyrinthine structure. Panels d and e, the
higher magnification of the squares in Fig. 3B. gi, trophoblast giant cells; la, labyrinthine
layer; ch, chorion.
TABLE 1
Genotyping analysis of embryos at term in TS cells rescue and
tetraploid rescue experiments
WT-TS cells injected into the SOCS3/ blastocysts significantly rescued the
embryonic lethality in SOCS3/ mice. To compare the efficiency, the ratio in
tetraploid rescue experiments was also described.
SOCS3 genotype
/ / / (e18.5)
TS cells injection 39 59 5(1dead)
Control (vehicle injection) 47 88 0
Tetraploid rescue 21 36 8
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